SCHEMBL21721048

SCHEMBL21721048

CC(C)c1ccc(N2CCN(C(C)(C)c3ccc(N4CCCC4)cc3)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2B6 P20813 1/20 0.44
CCR6 P51684 2/20 0.40
ALDH1A1 P00352 5/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 7/20 0.39
KDM4E B2RXH2 3/20 0.39
GAA P10253 3/20 0.39
ALOX15 P16050 3/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
PANK3 Q9H999 3/20 0.39
HTT P42858 3/20 0.39
TP53 P04637 2/20 0.39
THRB P10828 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
NPC1 O15118 1/20 0.39
USP2 O75604 1/20 0.39
POLB P06746 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21566474 0.88 CYP2B6 (0.51) CYP2B6ALDH1A1LMNAMAPTKDM4E
SCHEMBL277165 0.82 ALDH1A1 (0.54) ALDH1A1LMNAMAPTKDM4EGAA
SCHEMBL14923962 0.80 PANK3 (0.43) ALDH1A1LMNAMAPTKDM4EGAA
SCHEMBL22006730 0.80 ALDH1A1 (0.40) ALDH1A1LMNAMAPTKDM4EGAA
SCHEMBL18118180 0.80 ALDH1A1 (0.57) CCR6ALDH1A1LMNAMAPTKDM4E
SCHEMBL847809 0.80 ALDH1A1 (0.57) CCR6ALDH1A1LMNAMAPTKDM4E
SCHEMBL18118174 0.78 HPGD (0.52) ALDH1A1LMNAMAPTKDM4EGAA
SCHEMBL20251137 0.78 MAPT (0.51) ALDH1A1LMNAMAPTKDM4EGAA
SCHEMBL19273451 0.78 CYP2B6 (0.41) CYP2B6ALDH1A1LMNAMAPTKDM4E
SCHEMBL23544866 0.76 PANK3 (0.46) ALDH1A1LMNAMAPTKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10975084-B2 KDM5 inhibitors MERCK SHARP & DOHME CORP. (US) 2021-04-13 US disclosed
US-20200048258-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048258-A1 KDM5 INHIBITORS KDM5A, KDM5B, KDM5C CYP2B6 1838/4885CCR6 4414/4885ALDH1A1 1399/4885
US-10975084-B2 KDM5 inhibitors KDM5A, KDM5B, KDM5C CYP2B6 1838/4885CCR6 4414/4885ALDH1A1 1399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.